These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6457514)

  • 1. Insulin binding to erythrocytes in diabetes mellitus.
    Okada Y; Arima T; Okazaki S; Nakata K; Yamabuki T; Nagashima H
    Acta Med Okayama; 1981 Oct; 35(4):273-7. PubMed ID: 6457514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus.
    DePirro R; Fusco A; Lauro R; Testa I; Ferreti F; DeMartinis C
    Diabetes; 1980 Feb; 29(2):96-9. PubMed ID: 6986305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin receptors and interference by medication: in vivo and in vitro studies].
    Canivet B; Dolais-Kitabgi J; Freychet P
    Journ Annu Diabetol Hotel Dieu; 1982; ():61-70. PubMed ID: 7047843
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin binding of erythrocytes in hypoinsulinemic diabetics and its relationship to metabolic states.
    Oka Y; Ezaki O; Akanuma Y; Kosaka K
    Endocrinol Jpn; 1981 Oct; 28(5):615-22. PubMed ID: 7047154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and oral hypoglycemic agents.
    Price MJ
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin binding on erythrocytes in unsatisfactorily controlled obese diabetics (type 2) and nonobese diabetics (type 1).
    Páv J; Hilgertová J; Srámková J
    Exp Clin Endocrinol; 1985 Aug; 86(1):53-60. PubMed ID: 3902484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Content of immunoreactive insulin in the plasma and insulin sensitivity in patients with diabetes mellitus during the process of sulfanilamide compensation of metabolic disorders].
    Bogatyreva ShI; Dzeranova NIa; Shlimovich PB
    Probl Endokrinol (Mosk); 1972; 18(3):22-5. PubMed ID: 5029279
    [No Abstract]   [Full Text] [Related]  

  • 8. Sulfonylurea treatment of insulin-independent diabetes mellitus.
    Feinglos MN; Lebovitz HE
    Metabolism; 1980 May; 29(5):488-94. PubMed ID: 6990184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic control in 107 maturity onset diabetic out patients (author's transl)].
    Charitanski D; Blouquit Y; Papoz L; Soria J; Rosa J; Tchobroutsky G
    Nouv Presse Med; 1980 Feb; 9(9):585-9. PubMed ID: 6987621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of oral hypoglycemic agents in the therapeutic approach to diabetic obesity].
    Albert J; Ekoé JM
    Sem Hop; 1983 Sep; 59(29-30):2135-40. PubMed ID: 6312587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Round table talk about therapy of diabetes in Scandinavia. Surprising differences in the choice of therapy. Too little diet, too much tablets?].
    Karlsson Y
    Nord Med; 1976 Jun; 91(6-7-1):171-81. PubMed ID: 934791
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of diet alone, insulin, sulfonylureas, metformin, and thiazolidinediones with the severity of coronary artery disease in patients with diabetes mellitus.
    Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB
    Am J Ther; 2006; 13(5):400-3. PubMed ID: 16988534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes therapy using oral antidiabetics].
    Hasslacher C; Wahl P
    Z Allgemeinmed; 1972 Apr; 48(12):583-7. PubMed ID: 5034166
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of trimethoprim-sulfamethoxazole on blood insulin and glucose concentrations of diabetics.
    Mihic M; Mautner LS; Feness JZ; Grant K
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):80-2. PubMed ID: 1137831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte insulin binding abnormalities in fibro calculous pancreatic diabetes.
    Ramachandran A; Susheela L; Mohan V; Kuzali DA; Viswanathan M
    Horm Metab Res; 1988 Nov; 20(11):693-7. PubMed ID: 3063650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin cell receptors in diabetes caused by pancreatitis].
    Frati-Munari AC; Rodríguez-Rodríguez J; Altamirano P
    Arch Invest Med (Mex); 1987; 18(2):157-66. PubMed ID: 3310946
    [No Abstract]   [Full Text] [Related]  

  • 18. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
    Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
    Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-diabetic drugs].
    Smith SE
    Xianggang Hu Li Za Zhi; 1979 Nov; (27):24-5. PubMed ID: 397162
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of insulin receptor binding to monocytes and erythrocytes in newly diagnosed type II diabetes mellitus.
    Prager R; Schernthaner G
    Horm Metab Res; 1982 Nov; 14(11):561-3. PubMed ID: 6759349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.